Furthermore, CDK6 is reported as a critical factor for the survival of AML cells with FLT3‐ITD mutations, where FLT3‐ITD signaling is the primary cause of CDK6 overexpression through a pathway involving the SRC‐family kinase HCK.171. The gene discussed is CDK6; the disease is acute myeloid leukemia.